The medicinal product for treating throat diseases :: Consumers survey results of for 3 quarter of 2009

Consumers survey results of for 3 quarter of 2009 in category

Cold and Flu / The medicinal product for treating throat diseases

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.		Фарингосепт (Ranbaxy)	34.38%	5

2.	4	Гівалекс (Norgine Pharma)	21.88%	3.18

3.	2	Septolete (KRKA)	18.75%	2.73

4.	3	Strepsils (Reckitt Benckiser)	15.63%	2.27

4.		Себідин (GlaxoSmithKline)	15.63%	2.27

4.	~	Фарингін (GlaxoSmithKline)	15.63%	2.27

7.	4	Decatylen (Teva)	12.50%	1.82

7.	4	Септефрил (Борщагівський ХФЗ)	12.50%	1.82

9.	4	Імудон (Abbott Laboratories)	9.38%	1.36

9.		Інгаліпт (Pharmaceutical company “Zdorovya”)	9.38%	1.36

9.	~	Ангін-Хеель С (Heel)	9.38%	1.36

9.	3	Доктор Мом (Johnson & Johnson)	9.38%	1.36

9.	~	Кофол (Charak Pharma)	9.38%	1.36

9.	3	Орасепт (Bayer)	9.38%	1.36

9.	3	Трайсілс (Genom Biotech)	9.38%	1.36

16.	~	Ісла (Engelhard Arzneimittel)	6.25%	0.91

16.	~	Ангі-Септ др.Тайсс (Naturprodukt Vega (Dr. Theiss Naturwaren GmbH))	6.25%	0.91

16.	~	Граммидин (Холдинг Отечественные Лекарства)	6.25%	0.91

16.	2	Лісобакт (Bosnalijek)	6.25%	0.91

16.	~	Септалор (Ternopharm)	6.25%	0.91

16.	4	Трахисан (Engelhard Arzneimittel)	6.25%	0.91

16.	3	Фалімінт (Berlin-Chemie Menarini)	6.25%	0.91

23.	2	Інгаліпт-Н (Micropharm)	3.13%	0.45

23.	~	Ангинал (Др. Мюллер Фарма)	3.13%	0.45

23.	~	Асініс (Perrigo)	3.13%	0.45

23.	~	Йокс (Teva)	3.13%	0.45

23.	4	Каметон (Стома)	3.13%	0.45

23.	~	Колдакт Лор Пілс (Ranbaxy)	3.13%	0.45

23.	~	Пропосол-Н (Micropharm)	3.13%	0.45

–.	4	Eвкабал (Esparma)	0.00%	0

–.		Stopangin (Teva)	0.00%	0

–.	4	Аджисепт (Євролайфкер лімітед)	0.00%	0

–.		Ангін-Гран (Національна гомеопатична спілка)	0.00%	0

–.		Гексаліз (Lab. Bouchara-Recordati)	0.00%	0

–.		Гексаспрей (Lab. Bouchara-Recordati)	0.00%	0

–.	3	Ефізол (Actavis)	0.00%	0

–.	4	Каметон (Micropharm)	0.00%	0

–.		Камфомен (Стома)	0.00%	0

–.		Лінкас Лор (Herbion)	0.00%	0

–.	4	Нео-Ангін (Divapharma-Knufinke)	0.00%	0

–.		Плантіс Імуно + (Krauh Pharm)	0.00%	0

–.		Рекутан (ОЗ «ГНЦЛС»)	0.00%	0

–.		Септофіт (Actavis)	0.00%	0

–.	4	Суприма Лор (Shreya Life Sciences)	0.00%	0

–.	4	Тонзилгон Н (Bionorica)	0.00%	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2009, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.